30 Recruiting Studies Using Zimberelimab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Zimberelimab
A Study of Etrumadenant and Zimberelimab in People With Dedifferentiated Liposarcoma
📍 Memorial Sloan Kettering at Basking Ridge (Limited Protocol Activities) — Basking Ridge, New Jersey
Dedifferentiated Liposarcoma
View Study & Checklist ➔Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
📍 Innovative Clinical Research Institute — Whittier, California
Non-small Cell Lung Cancer
View Study & Checklist ➔Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
📍 Research Site — Columbus, Georgia
Non Small Cell Lung Cancer
View Study & Checklist ➔A Study to Evaluate the Safety and Tolerability of AB680 in Participants With Gastrointestinal Malignancies
📍 Research Site — Santa Monica, California
Advanced Pancreatic Cancer
View Study & Checklist ➔A Phase 2 Study to Evaluate the Triplet Combination of Pemetrexed Plus AB928 (Etrumadenant) + AB122 (Zimberelimab) in Patients With Previously Treated Advanced or Metastatic MTAP Deficient Urothelial Carcinoma
📍 MD Anderson Cancer Center — Houston, Texas
Urothelial Carcinoma
View Study & Checklist ➔Study of Novel Treatment Combination Therapies in Participants With Head and Neck Squamous Cell Carcinoma Regardless of PD-L1 Expression Status; Substudy-01
📍 Siteman Cancer Center — St Louis, Missouri
Head and Neck Squamous Cell Carcinoma
View Study & Checklist ➔Study of Novel Treatment Combinations in Patients With Lung Cancer
📍 Arizona Oncology Associates,Substudy-02 — Tucson, Arizona
Lung Cancer
View Study & Checklist ➔A Clinical Trial of a New Combination Treatment, Domvanalimab and Zimberelimab, Plus Chemotherapy, for People With an Upper Gastrointestinal Tract Cancer That Cannot be Removed With Surgery That Has Spread to Other Parts of the Body
📍 Research Site — Los Angeles, California
Advanced Upper Gastrointestinal Tract Adenocarcinoma
View Study & Checklist ➔Study of AB598 Monotherapy and Combination Therapy in Participants With Advanced Cancers
📍 Research Site — Phoenix, Arizona
Advanced Cancer
View Study & Checklist ➔Zimberelimab (AB122) With TIGIT Inhibitor Domvanalimab (AB154) in PD-1 Relapsed/Refractory Melanoma
📍 UPMC Hillman Cancer Center — Pittsburgh, Pennsylvania
Melanoma
View Study & Checklist ➔Study of GS-4528 in Adults With Solid Tumors
📍 The University of Washington/FHCC — Seattle, Washington
Solid Tumor
View Study & Checklist ➔Study of GS-9911 With or Without Antibody Treatment for Adults With Solid Tumors
📍 Smilow Cancer Hospital Phase 1 Unit — New Haven, Connecticut
Solid Tumors
View Study & Checklist ➔Domvanalimab and Zimberelimab in Advanced Liver Cancers
📍 University of Texas Southwestern Medical Center — Dallas, Texas
Hepatobiliary Cancer
View Study & Checklist ➔AB154 Combined With AB122 for Recurrent Glioblastoma
📍 University of California San Francisco — San Francisco, California
Glioblastoma
View Study & Checklist ➔Study With Various Immunotherapy Treatments in Participants With Lung Cancer
📍 University of Alabama at Birmingham (UAB) — Birmingham, Alabama
Advanced Non-Small Cell Lung Cancer
View Study & Checklist ➔A Safety and Efficacy Study of Treatment Combinations With and Without Chemotherapy in Adult Participants With Advanced Upper Gastrointestinal Tract Malignancies
📍 Research Site — Phoenix, Arizona
Gastrointestinal Tract Malignancies
View Study & Checklist ➔Study of Gemcitabine, Cisplatin, AB680 and AB122 During First Line Treatment of Advanced Biliary Tract Cancers (QUIC)
📍 Indiana University Melvin and Bren Simon Comprehensive Cancer Center — Indianapolis, Indiana
Biliary Tract Carcinoma
View Study & Checklist ➔Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer
📍 Washington University School of Medicine — St Louis, Missouri
Non Small Cell Lung Cancer
View Study & Checklist ➔Study of Denikitug (GS-1811) Given Alone or With Zimberelimab in Adults With Advanced Solid Tumors
📍 University of California San Diego — La Jolla, California
Advanced Solid Tumor
View Study & Checklist ➔A Clinical Trial to Assess COM503 in Participants With Advanced Solid Malignancies
📍 Yale- New Haven Hospital- Yale Cancer Center — New Haven, Connecticut
Neoplasm
View Study & Checklist ➔A Phase 1 Study of AB521 Monotherapy and Combination Therapies in Renal Cell Carcinoma and Other Solid Tumors
📍 Research Site — Birmingham, Alabama
Clear Cell Renal Cell Carcinoma
View Study & Checklist ➔Study of GS-2121 Given Alone or in Combination in Adults With Advanced Solid Tumors
📍 Stanford Cancer Center — Palo Alto, California
Advanced Solid Tumors
View Study & Checklist ➔Pre-NEOSHIFT-RCC: Neoadjuvant HIF-Inhibitor Immunotherapy in RCC
📍 Beth Israel Deaconess Medical Center — Boston, Massachusetts
Renal Cell Carcinoma
View Study & Checklist ➔Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer
📍 Columbia University Irving Medical Center / NewYork-Presbyterian Hospital — New York, New York
Oligometastatic Prostate Cancer
View Study & Checklist ➔A Phase I-II Study to Test the Safety and Efficacy of PD1 (AB122) and Adenosine Receptor (AB928) Antagonists With Chemotherapy After Short-Course Radiation for Rectal Cancer.
📍 Weill Cornell Medical College — New York, New York
Rectal Cancer
View Study & Checklist ➔Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
📍 Moffitt Cancer Center — Tampa, Florida
Breast Cancer
View Study & Checklist ➔Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma
📍 Yonemoto,Lisa — Los Angeles, California
Borderline Resectable Pancreatic Adenocarcinoma
View Study & Checklist ➔Study of Sacituzumab Govitecan in Participants With Urothelial Cancer That Cannot Be Removed or Has Spread
📍 The University of Arizona Cancer Center-North Campus — Tucson, Arizona
Metastatic Urothelial Cancer
View Study & Checklist ➔AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California
Borderline Resectable Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma
📍 Northwell Health R.J. Zuckerberg Cancer Center — Lake Success, New York
Pancreatic Ductal Adenocarcinoma
View Study & Checklist ➔